BIRC3 and B-cell chronic lymphocytic leukemia: The CLL driver mutations (with the exception of BIRC3 in pt-13) were detectable (by the presence of one or more mutated reads) at TP1 supporting the hypothesis that identification of mutations at diagnosis may identify individuals later requiring therapy.